31 March 2021 | News
Establishing a dedicated space in China for diagnostics companies to work through challenges and ultimately bring tests to market faster
Cytiva is opening a new design lab in Tonglu, the manufacturing site, close to Shanghai in East China. Here, diagnostics companies can access Cytiva’s diagnostic services without having to travel overseas to our other design lab in Germany.
Developing a lateral flow diagnostic is a complex process. By offering laboratory infrastructure, technical expertise, and consultation we help developers overcome technical hurdles and be ready to apply for regulatory approval.
The new lab is part of Cytiva’s global expansion plans, an investment of $500 million over five years to raise manufacturing capacity, announced in September 2020.
“In the last year, China has been extremely active. They accelerated the development of their COVID-19 tests and we see a lot of demand for diagnostic components,” says Emmanuel Abate, VP Genomics and Cellular Research at Cytiva.
“We have been manufacturing filtration products in Tonglu for many years and are now pleased to apply our assay design expertise to help local companies with their diagnostics projects. The expectations of this new lab are high and there are already a dozen design-in projects in this year’s pipeline.” says Eric Wu, Plant Manager for the Tonglu site.
The Tonglu site is a World Class Manufacturing site for filter paper. Powered by over 200 associates and a culture of continuous improvement, the site is ISO-accredited with digital and automation technologies. The new lab strengthens the commitment to the Tonglu area, an economic development zone.